Apogee Therapeutics, Inc. Accumulated Other Comprehensive Income
Apogee Therapeutics, Inc. (APGE) had Accumulated Other Comprehensive Income of -$2.50 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-10
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.50M.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$749.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.08M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.03M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$2.50M 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$749.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.08M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $1.03M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $685.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.07M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $915.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $3.27M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$289.00K 10-Q · filed 2024-08-12 |
| 2024-03-31 | -$177.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $329.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $135.00K 10-Q · filed 2023-11-13 |